Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1963 3
1965 1
2002 2
2003 6
2004 1
2005 3
2006 2
2007 2
2008 4
2009 1
2010 7
2011 6
2012 10
2013 12
2014 18
2015 18
2016 13
2017 8
2018 5
2019 15
2020 16
2021 17
2022 22
2023 12
2024 12
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion.
Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K; POPCORN Investigators. Soga Y, et al. Among authors: kawasaki d. J Am Heart Assoc. 2023 Jan 3;12(1):e025677. doi: 10.1161/JAHA.122.025677. Epub 2022 Dec 30. J Am Heart Assoc. 2023. PMID: 36583431 Free PMC article.
Efficacy and Safety of Endovascular Therapy for Aortoiliac TASC D Lesions.
Suzuki K, Mizutani Y, Soga Y, Iida O, Kawasaki D, Yamauchi Y, Hirano K, Koshida R, Kamoi D, Tazaki J, Higashitani M, Shintani Y, Yamaoka T, Okazaki S, Suematsu N, Tsuchiya T, Miyashita Y, Shinozaki N, Takahashi H, Inoue N. Suzuki K, et al. Among authors: kawasaki d. Angiology. 2017 Jan;68(1):67-73. doi: 10.1177/0003319716638005. Epub 2016 Mar 15. Angiology. 2017. PMID: 26980775
A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions: The SELUTION SFA Japan Trial.
Iida O, Soga Y, Saito S, Mano T, Hayakawa N, Ichihashi S, Kawasaki D, Suzuki K, Yamaoka T, Fujihara M, Nakama T, Nakamura M, Horie K, Shah T, Lansky A, Kozuki A. Iida O, et al. Among authors: kawasaki d. JACC Cardiovasc Interv. 2024 Jul 8;17(13):1547-1556. doi: 10.1016/j.jcin.2024.03.029. Epub 2024 Jun 5. JACC Cardiovasc Interv. 2024. PMID: 38842992 Free article. Clinical Trial.
Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value.
Gray WA, Soga Y, Fujihara M, Iida O, Babaev A, Kawasaki D, Zeller T, O'Connor D, Jaff MR, Chavez AM, Müller-Hülsbeck S. Gray WA, et al. Among authors: kawasaki d. J Comp Eff Res. 2024 Jun;13(6):e240025. doi: 10.57264/cer-2024-0025. Epub 2024 Apr 12. J Comp Eff Res. 2024. PMID: 38606556 Free PMC article. Clinical Trial.
1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice: Predictors of Restenosis and Aneurysmal Degeneration.
Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, Ichihashi S, Kozuki A, Nanto S, Sakata Y, Mano T; CAPSICUM Investigators. Iida O, et al. Among authors: kawasaki d. JACC Cardiovasc Interv. 2022 Mar 28;15(6):630-638. doi: 10.1016/j.jcin.2022.01.019. JACC Cardiovasc Interv. 2022. PMID: 35331454 Free article.
Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Hirano K, Soga Y, Tsubakimoto Y, Yokoi H, Miyamoto A, Nakamura M. Yamauchi Y, et al. Among authors: kawasaki d. Circ Cardiovasc Interv. 2020 Aug;13(8):e009168. doi: 10.1161/CIRCINTERVENTIONS.120.009168. Epub 2020 Jul 29. Circ Cardiovasc Interv. 2020. PMID: 32755323 No abstract available.
180 results